Associated Center:
Researcher(s) Keywords:
- Clinical Trial
- Chemotherapy
- Prognosis
- vaccines
- Biomarkers
- Lipidomics
- Glycomics
- proteomics
- Glycobiology
- Immunology
- Trypanosoma cruzi
- Chagas Disease
- Parasitology
- Microbiology
Featured Researcher(s):
Date: 17 June 2013 20:59

In a prestigious journal this year, researchers labeled Chagas disease as the new HIV/AIDS of the Americas. However, the epidemic may soon be facing its end, thanks to a recent development at The University of Texas at El Paso’s Border Biomedical Research Center (BBRC).
Igor C. Almeida, Ph.D., professor of biological sciences, has developed a fully protective vaccine against the parasite that causes the disease – Trypanosoma cruzi or T. cruzi.
Full story: [ Link to University Communications ]

